07 Jan 2001

Dexa-sine® | (Dexa-sine® Augentropfen) - Deutschland

Updated: 07 Jan 2001

Dexa-sine® | -SE

Behandl. v. nichtinfektiösen entzündl. Erkrank. der Bindehaut, der Hornhaut u. d. vorderen Augenabschnittes, auch Allergien, Reizungen, Verbrennungen u. Verätzungen.

Dexa-sine® | Description, Presentation and Dosage

Dexa-sine® | Description

Dexa-sine® | Drug Class Description

Einzelstoffe

Dexa-sine® | Drug Description

1 ml enth.: Dexamethasondihydrogenphosphat-Dinatrium 1 mg.

Dexa-sine® | Generic Name

Dexa-sine® Augentropfen

Dexa-sine® | Presentation

Dexa-sine® | Presentation

Dexa-sine®/-SE

Dexa-sine® | Manufacturer

Alcon

Related Learning Zones

LAL-D Knowledge Centre

LAL-D Knowledge Centre

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre contains a range of accurate, informative clinical content for healthcare professionals. The disease awareness section presents epidemiology, pathophysiology and diagnosis information, among others. The treatment section details the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency. The resources section contains further clinical content including a video channel presenting expert opinions on diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

Type 1 Childhood Diabetes CME

Type 1 Childhood Diabetes CME

In this EACCME-accredited online CME activity Individual Patient Management in Type 1 Childhood Diabetes, healthcare professionals will learn how to assess the psychosocial wellbeing of young patients with type 1 diabetes. 

Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC).

Dexa-sine® | Dosage

Dexa-sine® | Adult Dosage

Benzalkoniumchlorid, Dinatriumedetat 2H2O, Povidon, Natriumchlorid, Natriummonohydrogenphosphat 12H2O, gereinigtes Wasser.

Dexa-sine® | Child Dosage


Dexa-sine® SE Augentropfen in Einmaldosen
Zus.: 1 ml enth.: Dexamethasondihydrogenphosphat-Dinatrium 1,315 mg (entspr. 1 mg Dexamethason).
Weit. Bestandteile: Dinatriumedetat 2H2O, Natriumchlorid, Natriumdihydrogenphosphat 2H2O, Natriummonohydrogenphosphat H2O-frei, gereinigtes Wasser.

Dexa-sine® | Precautions, Reactions and Contraindications

Dexa-sine® | Special Precautions

Dexa-sine® | Special Precautions

G 13

Dexa-sine® | Adverse Reactions

Dexa-sine® | Adverse Reactions

G 13 a

Related Drugs - Eye Health and Disorders

Back to top